Evogene is a plant genomics company, utilizing a proprietary integrated technology infrastructure to enhance seed traits underlying crop productivity. Evogene offers a complete solution for crop productivity improvement through biotechnology and advanced breeding using a unique technology infrastructure that is based on deep scientific understandings of plant genomics and proprietary computational capabilities. The Company has strategic collaborations with world-leading agricultural companies to develop improved seed traits in relation to yield and a-biotic stress (such as tolerance to drought), and biotic stress (such as resistance to disease), in key crops as corn, soybean, wheat and rice. In addition, Evogene has earlier stage operations in agriculture chemicals, and seeds focusing on second generation feedstock for biodiesel. The Company's headquarters are located in Rehovot, Israel and is listed for trading on the Tel Aviv Stock Exchange (TASE: EVGN) and on the New York Stock Exchange (NYSE: EVGN).
Evogene – a burst of growth
Evogene's unique capabilities primarily stem from our multi-disciplinary team of talented professionals, allowing for the creativity and flexibility of an innovative company combined with the resources and large scale operations required for delivery of our massive discoveries. Our team includes biologists, agronomists, technicians, imaging experts and more, each contributing to our versatility and innovation.